Page last updated: 2024-08-16

timolol and Eyelid Neoplasms

timolol has been researched along with Eyelid Neoplasms in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's9 (90.00)24.3611
2020's1 (10.00)2.80

Authors

AuthorsStudies
Ojha, HR; Verma, N1
Hildebrand, GD; Jefferson, RJ1
Hildebrand, GD; Xue, K1
Rizvi, SA; Rizvi, SW; Sharma, R; Yusuf, F1
Hildebrand, GD; Painter, SL1
Guo, S; Ni, N1
Guo, S; Langer, P; Ni, N; Wagner, R1
Guo, S; Langer, P; Ni, N1
Escudero-Gómez, J; Fernández-Ballesteros, MD; Hiraldo-Gamero, A; Vera-Casaño, A1
Burón, I; Calvo, M; Fueyo-Casado, A; Garcia-Millán, C; Villegas, C1

Reviews

1 review(s) available for timolol and Eyelid Neoplasms

ArticleYear
Current concepts in the management of periocular infantile (capillary) hemangioma.
    Current opinion in ophthalmology, 2011, Volume: 22, Issue:5

    Topics: Administration, Oral; Administration, Topical; Adrenergic beta-Antagonists; Child, Preschool; Eyelid Neoplasms; Female; Hemangioma, Capillary; Humans; Infant; Male; Propranolol; Randomized Controlled Trials as Topic; Timolol; Treatment Outcome

2011

Other Studies

9 other study(ies) available for timolol and Eyelid Neoplasms

ArticleYear
Early management of capillary haemangioma to prevent stimulus-deprivation amblyopia.
    Nepalese journal of ophthalmology : a biannual peer-reviewed academic journal of the Nepal Ophthalmic Society : NEPJOPH, 2022, Volume: 14, Issue:28

    Topics: Amblyopia; Child; Eyelid Neoplasms; Female; Hemangioma, Capillary; Humans; Infant; Propranolol; Timolol

2022
Topical timolol treatment for periocular infantile haemangioma in the developing world.
    Tropical doctor, 2019, Volume: 49, Issue:3

    Topics: Administration, Topical; Adrenergic beta-Antagonists; Eyelid Neoplasms; Hemangioma, Capillary; Humans; Infant; Male; Timolol; Treatment Outcome

2019
Deep periocular infantile capillary hemangiomas responding to topical application of timolol maleate, 0.5%, drops.
    JAMA ophthalmology, 2013, Volume: 131, Issue:9

    Topics: Administration, Topical; Adrenergic beta-Antagonists; Eyelid Neoplasms; Female; Hemangioma, Capillary; Humans; Infant; Male; Ophthalmic Solutions; Timolol; Treatment Outcome; Visual Acuity

2013
Managment of superficial infantile capillary hemangiomas with topical timolol maleate solution.
    Seminars in ophthalmology, 2015, Volume: 30, Issue:1

    Topics: Administration, Topical; Adrenergic beta-Antagonists; Child, Preschool; Eyelid Neoplasms; Female; Hemangioma, Capillary; Humans; Infant; Male; Timolol; Treatment Outcome

2015
Topical timolol maleate 0.5% solution for the management of deep periocular infantile hemangiomas.
    Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus, 2016, Volume: 20, Issue:2

    Topics: Administration, Topical; Adrenergic beta-Antagonists; Amblyopia; Eyelid Neoplasms; Female; Hemangioma, Capillary; Humans; Infant; Male; Neoplastic Syndromes, Hereditary; Ophthalmic Solutions; Orbital Neoplasms; Retrospective Studies; Timolol

2016
Topical treatment for capillary hemangioma of the eyelid using beta-blocker solution.
    Archives of ophthalmology (Chicago, Ill. : 1960), 2010, Volume: 128, Issue:2

    Topics: Administration, Topical; Adrenergic beta-Antagonists; Eyelid Neoplasms; Female; Hemangioma, Capillary; Humans; Infant; Retinoscopy; Timolol; Treatment Outcome; Visual Acuity

2010
Topical timolol for periocular hemangioma: report of further study.
    Archives of ophthalmology (Chicago, Ill. : 1960), 2011, Volume: 129, Issue:3

    Topics: Administration, Topical; Adrenergic beta-Antagonists; Eyelid Neoplasms; Facial Neoplasms; Female; Hemangioma, Capillary; Humans; Infant; Timolol

2011
[Infantile hemangioma of the eyelid treated with timolol gel].
    Actas dermo-sifiliograficas, 2012, Volume: 103, Issue:5

    Topics: Eyelid Neoplasms; Female; Gels; Hemangioma; Humans; Infant; Timolol

2012
Topical timolol for infantile hemangioma of the eyelid.
    International journal of dermatology, 2013, Volume: 52, Issue:5

    Topics: Administration, Cutaneous; Adrenergic beta-Antagonists; Eyelid Neoplasms; Hemangioma, Capillary; Humans; Infant, Newborn; Male; Neoplastic Syndromes, Hereditary; Ophthalmic Solutions; Timolol

2013